Press Releases :: ContraFect Corporation (CFRX)

Press Releases

Investors & Media

ContraFect Corporation's Universal Influenza Treatment Receives SBIR Funding

September 16, 2014

ContraFect Corporation Announces Separation of Units Sold in IPO

September 9, 2014

ContraFect Corporation to Present at the Rodman & Renshaw 16th Annual Healthcare Conference

September 3, 2014

ContraFect Corporation Showcases CF-301 at ICAAC 2014 Meeting in Washington, D.C.

September 2, 2014

ContraFect Corporation Announces Exercise of Initial Public Offering Over-Allotment Option

August 27, 2014

ContraFect Corporation Announces Closing of Initial Public Offering

August 4, 2014

ContraFect Announces Pricing of Its Initial Public Offering

July 29, 2014

Journal of Infectious Diseases Publishes ContraFect Corporation's Scientific Research

May 13, 2014

ContraFect Corporation Confirms Appointment of Julia P. Gregory as CEO and Director, and Appoints David N. Low, Michael J. Otto and Roger J. Pomerantz to Board of Directors

April 24, 2014

ContraFect Announces Management Team Changes

November 21, 2013